Insiders who reported open-market trades in the last 12 months at the companies David P. Bonita files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
ORBIMED ADVISORS LLC - $12.50M in PRLD purchases and sales in the last 12 months
David P. Bonita is a corporate insider of ImageneBio, Inc. (IMA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David P. Bonita last file a Form 4?
The most recent primary Form 4 on record is dated 18 June 2026, one of 6 filings going back to 2025.
Has David P. Bonita been buying or selling stock?
Recorded transactions: 5 open-market purchases ($15.00M) and 0 open-market sales across all tracked filings.
David P. Bonita files SEC Form 4 reports at ImageneBio, Inc. (IMA). 6 SEC Form 4 filings on record going back to 2025, most recently on 18 June 2026. Most recent open-market trade: bought $5.00M of PRLD on 23 April 2026. Lifetime open-market purchases: $15.00M.
Recent transactions
5
The latest 5 SEC Form 4 transactions reported by David P. Bonita.
InsiderAlpha's records for David P. Bonita go back to 2025: 6 primary Form 4 filings, an average of 3.0 per year. The typical open-market purchase is $5.00M (3 of 5 buys carry a usable dollar value, totaling $15.00M). The largest single buy on record is $7.50M of PRLD in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
